Multiple cellular pathways and gene expression networks

The term Multiple cellular pathways and gene expression networks does not refer to a single, discrete therapeutic target such as a specific protein, receptor, or enzyme. Instead, it describes the integrated and complex systems of biochemical signaling and genetic regulatory circuits that dictate cellular behavior and phenotype. In the context of drug discovery, a valid target is typically defined as a distinct molecular entity whose activity can be modulated to achieve a specific therapeutic outcome (Source: NIH National Center for Advancing Translational Sciences). This phrase is often used in scientific literature to describe the broad, multi-faceted effects of a drug or the systemic changes associated with complex disease states like cancer or autoimmunity. Because it encompasses a vast array of independent and overlapping molecular interactions, it lacks the specificity required for a canonical drug target. Consequently, it cannot be mapped to a single mechanism of action or a specific molecular classification. It represents the holistic biological landscape rather than a point of pharmacological intervention.

Not applicable as this refers to a broad collection of biological processes rather than a discrete molecular target.